(Q44953745)

English

Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopri

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopri (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

congestive heart failure

1 reference

based on heuristic

inferred from title

Paul W. Armstrong

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Sumit R Majumdar

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Finlay A McAlister

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Marilyn Cree

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Wei-Ching Chang

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Milton Packer

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ATLAS Study Group

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

694-703

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Insights into the contemporary epidemiology and outpatient management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Underutilisation of ACE inhibitors in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of care for patients hospitalized with heart failure at academic medical centers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes in heart failure: report from a community hospital-based registry

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis and Determinants of Survival in Patients Newly Hospitalized for Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The Postmenopausal Estrogen/Progestin Interventions Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-blockers in congestive heart failure. A Bayesian meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

End of the oldest controversy in medicine. Are we ready to conclude the debate on digitalis?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical benefits of low serum digoxin concentrations in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose digoxin in patients with heart failure. Less toxic and at least as effective?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the diagnosis and treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

New therapeutic options in congestive heart failure: Part II.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin receptor blockers in heart failure: a work in progress

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Are surrogate markers adequate to assess cardiovascular disease drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Are we asking too much of our trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990069-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(04)90069-0

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44953745&oldid=1634805000"